|
FI75561C
(fi)
*
|
1979-10-30 |
1988-07-11 |
Ciba Geigy Ag |
Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
|
|
EP0108715A1
(de)
*
|
1982-10-15 |
1984-05-16 |
Ciba-Geigy Ag |
Dibenzazepincarboxamide
|
|
FR2700117B1
(fr)
*
|
1993-01-07 |
1995-02-03 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
|
|
US5472714A
(en)
*
|
1993-09-08 |
1995-12-05 |
Ciba-Geigy Corporation |
Double-layered oxcarbazepine tablets
|
|
IT1272897B
(it)
*
|
1995-01-13 |
1997-07-01 |
I F C Iniziative Finanziaarie |
Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
|
|
PT101732B
(pt)
*
|
1995-06-30 |
1997-12-31 |
Portela & Ca Sa |
Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
|
|
PT101876B
(pt)
*
|
1996-05-27 |
1999-09-30 |
Portela & Ca Sa |
Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida
|
|
US20020022056A1
(en)
*
|
1997-02-14 |
2002-02-21 |
Burkhard Schlutermann |
Oxacarbazepine film-coated tablets
|
|
AT406957B
(de)
*
|
1998-11-25 |
2000-11-27 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur oxidation von methyl-, methylen- oder methingruppen enthaltenden substraten
|
|
DE59902734D1
(de)
|
1998-11-25 |
2002-10-24 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur Oxidation von Methyl-, Methylen- oder Methingruppen enthaltenden Substraten
|
|
GB9930058D0
(en)
|
1999-12-20 |
2000-02-09 |
Novartis Ag |
Organic compounds
|
|
IT1317854B1
(it)
*
|
2000-02-25 |
2003-07-15 |
Farchemia Srl |
5-ciano-10-idrossi-10,11-diidro-5h-dibenz(b,f)azepina e procedimentiper la sua preparazione e per la sua conversione in
|
|
EP1368322A4
(en)
*
|
2001-02-12 |
2004-03-17 |
Teva Pharma |
NOVEL CRYSTALLINE FACIES OF OXCARBAZEPINE AND PROCESSES FOR THEIR PREPARATION
|
|
TW200501962A
(en)
*
|
2003-04-01 |
2005-01-16 |
Novartis Ag |
Use of carbamazepine derivatives for the treatment of agitation in dementia patients
|
|
JP2007513056A
(ja)
|
2003-09-03 |
2007-05-24 |
ノバルティス アクチエンゲゼルシャフト |
糖尿病性神経因性疼痛の処置および睡眠の改善のためのオキシカルバゼピンの使用
|
|
WO2005066133A2
(en)
*
|
2003-10-20 |
2005-07-21 |
Amoli Organics Ltd. |
NOVEL PROCESS FOR PREPARATION OF 10-OXO-10, 11-DIHYDRO-5H-DIBENZ [b,f]AZEPINE-5-CARBOXAMIDE (OXCARBAZEPINE) VIA INTERMEDIATE, 10-METHOXY-5H-DIBENZ[b,f] AZEPINE-5-CARBONYLCHLORIDE
|
|
ITMI20040452A1
(it)
*
|
2004-03-09 |
2004-06-09 |
Clariant Lsm Italia Spa |
Processo per la preparazione di oxcarbazepina
|
|
US7459553B2
(en)
*
|
2004-03-11 |
2008-12-02 |
Glenmark Generics Ltd. |
Process for the preparation of carboxamide compounds
|
|
WO2005096709A2
(en)
*
|
2004-03-11 |
2005-10-20 |
Sun Pharmaceutical Industries Limited |
A process for the preparation of 10,11-dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide
|
|
EP1600443A1
(en)
*
|
2004-05-26 |
2005-11-30 |
Alberto Milanese |
Process for the preparation of oxcarbazepine
|
|
CA2471666C
(en)
*
|
2004-06-18 |
2009-10-13 |
Apotex Pharmachem Inc. |
An improved process for the preparation of oxcarbazepine and related intermediates
|
|
US20060252745A1
(en)
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
|
MX2008013675A
(es)
|
2006-04-26 |
2009-03-06 |
Supernus Pharmaceuticals Inc |
Preparaciones de liberacion controlada de oxcarbacepina que tienen perfil de liberacion sigmoidal.
|
|
GB0700773D0
(en)
|
2007-01-15 |
2007-02-21 |
Portela & Ca Sa |
Drug therapies
|
|
US20090082335A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched oxcarbazepine
|
|
WO2009073154A1
(en)
|
2007-11-28 |
2009-06-11 |
Nektar Therapeutics Al, Corporation |
Oligomer-tricyclic conjugates
|
|
US8530647B2
(en)
*
|
2008-05-08 |
2013-09-10 |
Mylan Laboratories Limited |
Process for the preparation of oxcarbazepine
|
|
WO2011091050A1
(en)
|
2010-01-19 |
2011-07-28 |
Nektar Therapeutics |
Oligomer-tricyclic conjugates
|
|
WO2014049550A1
(en)
|
2012-09-26 |
2014-04-03 |
Ranbaxy Laboratories Limited |
Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate
|
|
MX2018008021A
(es)
|
2015-12-30 |
2018-11-09 |
Adamas Pharmaceuticals Inc |
Metodos y composiciones para el tratamiento de trastornos relacionados con convulsiones.
|
|
HRP20220463T1
(hr)
|
2016-12-16 |
2022-05-27 |
Idorsia Pharmaceuticals Ltd |
Farmaceutska kombinacija koja sadrži blokator kalcijevih kanala t-tipa
|
|
US10639313B2
(en)
|
2017-09-01 |
2020-05-05 |
Ndsu Research Foundation |
Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
|
|
EP3856196B1
(en)
|
2018-09-28 |
2023-11-15 |
Griffith University |
Phenylpropionic acid derivatives for modulating pathogen activity
|